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Abstract
Nonsense-mediated mRNA decay (NMD) downmodulates mRNAs that have in-frame premature
termination codons and prevents translation of potentially harmful truncated proteins from
aberrant mRNAs. Two new approaches have identified physiological NMD substrates, and
suggest that NMD functions as a multipurpose tool in the modulation of gene expression.
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Nonsense-mediated mRNA decay (NMD) is a specific
pathway for the degradation of mRNAs that have premature
termination codons (PTCs) in their open reading frames
(ORFs). Its importance is highlighted by its conservation in
all eukaryotes. NMD counteracts the potentially harmful
impact of mRNAs that have PTCs as a result of errors at
various levels of gene expression, such as nonsense and
frameshift mutations, transcriptional errors and faulty
splicing. Thus, NMD serves as a ‘cellular vacuum cleaner’
that protects the cell from the potentially harmful effects of
truncated proteins by eliminating mRNAs with PTCs in a
sequence of events that is not yet fully understood. In
recent years numerous biochemical and cell-biological
investigations in Saccharomyces cerevisiae [1], Drosophila
melanogaster [2], Caenorhabditis elegans [3] and human
[4,5] cells have helped to elucidate some of the mechanistic
details underlying the NMD pathway. A role for NMD in the
regulation of mRNA metabolism beyond the mere vacuum
cleaner function for faulty mRNAs has been suspected, and
was foreshadowed by work on the splicing factor SC35 and
some ribosomal proteins [6,7]. Now, ‘genome-wide’
approaches - one in yeast using microarrays and another in
silico, analyzing information mined from mRNA and protein
databases - have added powerful evidence to suggest that
NMD may serve multiple purposes in gene expression [8-11]. 
Inspirations from yeast
In yeast, NMD depends on the expression of the Upf1, Upf2
(Nmd2) and Upf3 proteins. Single or simultaneous inactiva-
tion of the UPF genes stabilizes nonsense-containing
mRNAs, indicating that their protein products interact func-
tionally in the same pathway. He et al. [8] used high-density
oligonucleotide arrays to analyze genome-wide expression
profiles of yeast strains containing single deletions of the
UPF1, UPF2 or UPF3 genes, as well as of the DCP1 and XRN1
genes which encode proteins with activities thought to be
involved in the NMD pathway - an essential component of the
mRNA decapping enzyme and the 5-3 exonuclease, respec-
tively. They also tested double deletions of the XRN1 gene in
combination with each of the UPF genes. Two-dimensional
clustering analysis of the expressed genes for the upf1,
upf2 and upf3 strains yielded several interesting results.
The deletion of UPF1, UPF2 or UPF3 generated nearly iden-
tical expression profiles. Thus, all three gene products act onthe same targets, consistent with the function of Upf1, Upf2
and Upf3 in a single, linear pathway in yeast. The abundance
of most mRNAs upregulated in Upf-deficient cells was also
increased in dcp1 and xrn1 strains, suggesting that these
mRNAs are largely degraded by decapping and subsequent
5-3 exonucleolytic decay. This approach also identified a
considerable number of NMD-regulated transcripts (765 out
of the 7,839 genes represented on the microarrays) and
showed that NMD substrates are generally expressed at
below-average levels. In addition, most NMD substrates
were found to be upregulated upon NMD inactivation, but
some were downregulated, pointing to the existence of
higher-order NMD targets (or additional functions of the
Upf proteins in alternative gene-regulation pathways).
Finally, only one third of the identified transcripts can be
classified into structural or functional groups, some of which
are surprising and hitherto unrecognized. Representatives of
previously described NMD-substrate categories were identi-
fied, including mRNAs with nonsense mutations, transcripts
resulting from faulty or regulated alternative splicing,
mRNAs subject to leaky scanning during translation initia-
tion, and mRNAs with an upstream ORF or with AATGA or
ATGAA motifs immediately upstream of their translation
initiation codons. More intriguing is the discovery of several
new classes of NMD targets, including mRNAs that use
translational +1 frameshifting, bicistronic mRNAs and, most
interestingly, two classes of noncoding RNAs: pseudogene
transcripts and transcripts encoded by transposable elements
or their long terminal repeat (LTR) sequences. 
A significant fraction of the protein-encoding transcripts
upregulated in the strains with mutations in the NMD-
pathway genes [8] could be grouped into clusters of proteins
that act in similar pathways. Among these are proteins coor-
dinately involved in telomere maintenance, pre-mRNA splic-
ing, peroxisomal function and DNA repair. This suggests the
exciting possibility that NMD could orchestrate the expres-
sion of functional groups of genes. Several important results
of the work by He et al. [8] confirm findings obtained by
another lab using a similar approach several years ago [12].
Notably, the coordinate upregulation of genes involved in
telomere maintenance by NMD inactivation has already
sparked interesting follow-up investigations. The yeast NMD
pathway has been shown to accelerate the rate of senescence
promoted by the loss of the telomerase enzyme or by the
erosion of telomeres that results from altering the stochiom-
etry of telomere-cap components [13-15]. At least one likely
primary target of NMD is the mRNA of Stn1p, an essential
protein involved in chromosome-end protection. The obser-
vation by He et al. [8] that 35.9% of all ORFs encoded in the
telomere region were upregulated in strains with mutations
in components of the NMD pathway further illustrates that
NMD controls many genes near telomere ends, although
probably indirectly. These genes are usually silenced and
may be derepressed when the protection of chromosome
ends is disturbed by the loss of NMD. This enlightening
example demonstrates how NMD can affect whole pathways
by regulating the expression of one or a few primary target
mRNAs, with consequences for groups of downstream sec-
ondary effectors. The discovery of additional examples of
NMD-mediated control of functional pathways can be
expected, promoting NMD to a gene-expression tool with
many utilities. The cellular vacuum cleaner has therefore
become a Swiss army knife (Figure 1).
In silico veritas?
In a series of three recent publications [9-11] Steve Brenner
and colleagues suggested, by data-mining, that one-third of
reliably inferred human splice products form a major class of
natural targets for NMD. Alternative splicing is thought to
occur in 30-60% of human genes, expanding the coding reper-
toire of the limited number of genes in the genome and modu-
lating tissue-specific and developmental gene functions.
Brenner and colleagues [9-11] now suggest that alternative
splicing provides a mechanism to generate PTC-containing
splice products that are subsequently degraded by NMD and,
as a consequence, that cooperation between alternative splic-
ing and NMD pathways offers a major and currently underap-
preciated way to regulate gene expression. 
For their in silico analysis, they mapped well-characterized
human RefSeq [16] and LocusLink [17] mRNA sequences to
genomic sequences, and then performed high-stringency
alignments between these ‘RefSeq-coding genes’ and
expressed sequence tags (ESTs). The reliably inferred splice
variants were only accepted as likely NMD targets when they
conformed to the ‘50-nucleotide rule’: this hallmark of mam-
malian NMD predicates that stop codons located at least 50
nucleotides upstream of the last exon junction will be inter-
preted as ‘premature’ and trigger NMD. This approach leads
to an underestimate of potential NMD targets, because some
PTCs (for example, in T-cell receptor gene transcripts) will
trigger NMD even when they are not followed by a sufficiently
distant intron [18]. Moreover, Brenner and colleagues [9-11]
also excluded mRNA variants that are indistinguishable from
products of faulty splicing. These studies have unearthed
several groups of functionally related proteins whose expres-
sion appears to be regulated by NMD, including translation
factors and ribosomal proteins. This is in remarkable contrast
to the yeast data of He et al. [8], where proteins with a func-
tion in translation were, if anything, underrepresented in the
pool of NMD-regulated genes. 
NMD is not (yet) on everyone’s mind. As a consequence,
Brenner and colleagues [11] found several entries for trun-
cated proteins in the Swiss-Prot database. In some of these
cases the available experimental evidence confirms that the
mRNAs that encode these truncated proteins are bona fide
NMD substrates. We are left with a consolation and a sur-
prise. The consolation is that traces of NMD can be uncov-
ered even though they had been overlooked before. Having
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human genome is too limited to explain the far higher
number of proteins (not to mention other gene products), we
then had to learn that one plausible and elegant explanation
lies in alternative splicing, which enables a gene to code for a
whole family of related, or sometimes antagonistic, proteins.
And now the surprise is that a large portion of this effort is
supposedly expended only to direct many of the primary
products to decay. Several conclusions can be drawn from
these observations. First, databases need to be read and
annotated with a full realization of the implications of NMD;
and second, NMD seems to serve as a tool for rapidly switch-
ing off gene expression. This view extends the idea of NMD as
a mechanism for ridding the cell of the potentially harmful
products of faulty splicing. But there may be more to it. NMD
rarely downregulates the expression of a transcript com-
pletely; more commonly, 10-30% of the PTC-containing
transcripts survive and may allow the production of physio-
logically relevant levels of truncated protein products. 
For NMD researchers it has always been hard to reconcile
these observations with the presumed protective role of
NMD, especially as very low levels of biological products can
sometimes have enormous effects. Given the problems of
detecting the low levels of proteins or peptides produced
from downregulated transcripts, in addition to some linger-
ing lack of awareness of NMD, examples to prove otherwise
are hard to come by. A recent publication [19] describes a
PTC-containing transcript of the high-affinity immunoglob-
ulin E (IgE) receptor, FcRI, arising from retention of an
intron. This alternative transcript not only conforms to the
50-nucleotide rule but its expression levels are very low
compared to those of the full-length transcript, as would be
expected for an NMD target. Nonetheless, the truncated
protein is not only detectable, it even competes effectively
with the full-length protein to control FcRI expression on
the cell surface. Thus, even low endogenous expression
levels of NMD targets can suffice to generate a product with
a biological function. A similar example of the utility of a
bona fide NMD substrate is illustrated by the unc-49 locus in
C. elegans. This locus uses alternative splicing to produce
three GABA-receptor subunits, two of which (A and B)
undergo several splice events in their 3 UTRs, rendering
them predicted NMD substrates [20]. While A-form tran-
scripts are hardly detectable, B-form transcripts represent
the most abundant form and code for a protein essential for
the worm’s locomotion. Either the B-form transcript escapes
NMD, or the residual mRNA left after NMD suffices for the
necessary protein production. 
Among the examples presented by Brenner and colleagues
[11] or in other studies [21] are genes with complex alterna-
tive splice patterns resulting in multiple transcript isoforms
with or without PTCs. The lower abundance of these iso-
forms when compared to the full-length form supports the
notion that they are targeted to the NMD pathway. But is the
possibility that cells engage in complex alternative-splicing
procedures generating multiple products, just to finally
dispose of them, the only conceivable option? Four out of
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Figure 1
The role of NMD. (a) Until recently the role of NMD has been
predominantly seen as that of a cellular ‘vacuum cleaner’ that rids the cell
of erroneous mRNAs. (b) Now a more sophisticated picture of NMD is
emerging - a highly specific and delicate multipurpose tool that contributes at
multiple levels to the control and balance of physiological gene expression.
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death receptor are readily detectable in non-activated lym-
phocytes, whereas only the full-length form is expressed in
activated lymphocytes [11]. While it is entirely possible that
the PTC-containing forms are generated to switch off recep-
tor expression in resting lymphocytes, there are attractive
alternatives: as in the case of the FcRI receptor [19], the
PTC-containing mRNAs may produce proteins or peptides
with relevant, although currently unknown, functions. Thus,
quantitative control of the expression of low amounts of
protein isoforms could represent yet another facet of the
function of the NMD pathway. 
A role for NMD in controlling the levels of noncoding RNAs
(including noncoding alternative splice products) must also
be considered. RNA accounts for more than 95% of the
human genome’s output and there is increasing evidence
that noncoding RNAs (including introns, and spliced and
polyadenylated transcripts) can have a function, for example
as a modulating network or an additional layer of informa-
tion [22,23]. Importantly, noncoding RNAs have been dis-
covered among natural NMD targets in yeast [8], where only
a relatively small portion of the genome is transcribed into
noncoding RNAs. What might be the role of NMD in
mammals, which transcribe a far higher percentage of their
genome into noncoding RNAs [22,24,25]? Clearly, the recent
insights into the RNA-substrate spectrum of the NMD
system should enhance the appreciation of NMD as a versa-
tile, multipurpose mechanism that controls the transcriptome
qualitatively and quantitatively.
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